Literature DB >> 23190243

HIF2A mutations in paraganglioma with polycythemia.

Judith Favier, Alexandre Buffet, Anne-Paule Gimenez-Roqueplo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23190243     DOI： 10.1056/NEJMc1211953

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  31 in total

1.  Genotype-phenotype correlations in pheochromocytoma and paraganglioma: a systematic review and individual patient meta-analysis.

Authors:  Joakim Crona; Angela Lamarca; Suman Ghosal; Staffan Welin; Britt Skogseid; Karel Pacak
Journal:  Endocr Relat Cancer       Date:  2019-05       Impact factor: 5.678

Review 2.  Rodent models of pheochromocytoma, parallels in rodent and human tumorigenesis.

Authors:  Charlotte Lussey-Lepoutre; Alexandre Buffet; Aurélie Morin; Judith Goncalves; Judith Favier
Journal:  Cell Tissue Res       Date:  2018-02-09       Impact factor: 5.249

3.  Progress in Endocrine Neoplasia.

Authors:  Samuel A Wells
Journal:  Clin Cancer Res       Date:  2016-10-15       Impact factor: 12.531

Review 4.  Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity.

Authors:  Patricia L M Dahia
Journal:  Nat Rev Cancer       Date:  2014-01-20       Impact factor: 60.716

Review 5.  Role of hypoxia and HIF2α in development of the sympathoadrenal cell lineage and chromaffin cell tumors with distinct catecholamine phenotypic features.

Authors:  Susan Richter; Nan Qin; Karel Pacak; Graeme Eisenhofer
Journal:  Adv Pharmacol       Date:  2013

6.  A nomogram for predicting the presence of germline mutations in pheochromocytomas and paragangliomas.

Authors:  Ting Wei Su; Xu Zhong; Lei Ye; Wei Song; Lei Jiang; Jing Xie; Yiran Jiang; Weiwei Zhou; Cui Zhang; Luming Wu; Guang Ning; Weiqing Wang
Journal:  Endocrine       Date:  2019-10-12       Impact factor: 3.633

7.  First report of bilateral pheochromocytoma in the clinical spectrum of HIF2A-related polycythemia-paraganglioma syndrome.

Authors:  David Taïeb; Chunzhang Yang; Blandine Delenne; Zhengping Zhuang; Anne Barlier; Fréderic Sebag; Karel Pacak
Journal:  J Clin Endocrinol Metab       Date:  2013-03-28       Impact factor: 5.958

8.  In vivo and in vitro oncogenic effects of HIF2A mutations in pheochromocytomas and paragangliomas.

Authors:  Rodrigo A Toledo; Yuejuan Qin; Subramanya Srikantan; Nicole Paes Morales; Qun Li; Yilun Deng; Sang-Woo Kim; Maria Adelaide A Pereira; Sergio P A Toledo; Xiaoping Su; Ricardo C T Aguiar; Patricia L M Dahia
Journal:  Endocr Relat Cancer       Date:  2013-05-21       Impact factor: 5.678

Review 9.  Genetics of pheochromocytoma and paraganglioma syndromes: new advances and future treatment options.

Authors:  Ales Vicha; Zdenek Musil; Karel Pacak
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2013-06       Impact factor: 3.243

10.  Novel insights into the polycythemia-paraganglioma-somatostatinoma syndrome.

Authors:  Roland Därr; Joan Nambuba; Jaydira Del Rivero; Ingo Janssen; Maria Merino; Milena Todorovic; Bela Balint; Ivana Jochmanova; Josef T Prchal; Ronald M Lechan; Arthur S Tischler; Vera Popovic; Dragana Miljic; Karen T Adams; F Ryan Prall; Alexander Ling; Meredith R Golomb; Michael Ferguson; Naris Nilubol; Clara C Chen; Emily Chew; David Taïeb; Constantine A Stratakis; Tito Fojo; Chunzhang Yang; Electron Kebebew; Zhengping Zhuang; Karel Pacak
Journal:  Endocr Relat Cancer       Date:  2016-09-27       Impact factor: 5.678
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.